A citation-based method for searching scientific literature

Brian F Gage, Anne R Bass, Hannah Lin, Scott C Woller, Scott M Stevens, Noor Al-Hammadi, Juan Li, Tomás Rodríguez, J Philip Miller, Gwendolyn A McMillin, Robert C Pendleton, Amir K Jaffer, Cristi R King, Brandi DeVore Whipple, Rhonda Porche-Sorbet, Lynnae Napoli, Kerri Merritt, Anna M Thompson, Gina Hyun, Jeffrey L Anderson, Wesley Hollomon, Robert L Barrack, Ryan M Nunley, Gerard Moskowitz, Victor Dávila-Román, Charles S Eby. JAMA 2017
Times Cited: 144







List of co-cited articles
752 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
566
60

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
526
54

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
298
52

Estimation of the warfarin dose with clinical and pharmacogenetic data.
T E Klein, R B Altman, N Eriksson, B F Gage, S E Kimmel, M-T M Lee, N A Limdi, D Page, D M Roden, M J Wagner,[...]. N Engl J Med 2009
34

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
B F Gage, C Eby, J A Johnson, E Deych, M J Rieder, P M Ridker, P E Milligan, G Grice, P Lenzini, A E Rettie,[...]. Clin Pharmacol Ther 2008
565
25

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
Minoli A Perera, Larisa H Cavallari, Nita A Limdi, Eric R Gamazon, Anuar Konkashbaev, Roxana Daneshjou, Anna Pluzhnikov, Dana C Crawford, Jelai Wang, Nianjun Liu,[...]. Lancet 2013
182
20

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Jessica L Mega, Joseph R Walker, Christian T Ruff, Alexander G Vandell, Francesco Nordio, Naveen Deenadayalu, Sabina A Murphy, James Lee, Michele F Mercuri, Robert P Giugliano,[...]. Lancet 2015
123
18

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
J A Johnson, L Gong, M Whirl-Carrillo, B F Gage, S A Scott, C M Stein, J L Anderson, S E Kimmel, M T M Lee, M Pirmohamed,[...]. Clin Pharmacol Ther 2011
437
17

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
Nicholas L Syn, Andrea Li-Ann Wong, Soo-Chin Lee, Hock-Luen Teoh, James Wei Luen Yip, Raymond Cs Seet, Wee Tiong Yeo, William Kristanto, Ping-Chong Bee, L M Poon,[...]. BMC Med 2018
25
68

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
613
16


Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, Rhonda M Cooper-DeHoff, Julio D Duarte, Deepak Voora, Stephen E Kimmel, Caitrin W McDonough, Yan Gong, Chintan V Dave,[...]. JACC Cardiovasc Interv 2018
160
15

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
14

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Nita A Limdi, Mia Wadelius, Larisa Cavallari, Niclas Eriksson, Dana C Crawford, Ming-Ta M Lee, Chien-Hsiun Chen, Alison Motsinger-Reif, Hersh Sagreiya, Nianjun Liu,[...]. Blood 2010
268
14

CYP4F2 genetic variant alters required warfarin dose.
Michael D Caldwell, Tarif Awad, Julie A Johnson, Brian F Gage, Mat Falkowski, Paul Gardina, Jason Hubbard, Yaron Turpaz, Taimour Y Langaee, Charles Eby,[...]. Blood 2008
389
14

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
Fumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, Chris Barnes, Niclas Eriksson, Nicole Soranzo, Pamela Whittaker, Venkatesh Ranganath, Vasudev Kumanduri, William McLaren,[...]. PLoS Genet 2009
461
13

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Talitha I Verhoef, Georgia Ragia, Anthonius de Boer, Rita Barallon, Genovefa Kolovou, Vana Kolovou, Stavros Konstantinides, Saskia Le Cessie, Efstratios Maltezos, Felix J M van der Meer,[...]. N Engl J Med 2013
170
13

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients.
Sheng-Wen Huang, Hai-Sheng Chen, Xian-Qun Wang, Ling Huang, Ding-Li Xu, Xiao-Jia Hu, Zhi-Hui Huang, Yong He, Kai-Ming Chen, Dao-Kang Xiang,[...]. Pharmacogenet Genomics 2009
125
13

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Mark J Rieder, Alexander P Reiner, Brian F Gage, Deborah A Nickerson, Charles S Eby, Howard L McLeod, David K Blough, Kenneth E Thummel, David L Veenstra, Allan E Rettie. N Engl J Med 2005
12

The largest prospective warfarin-treated cohort supports genetic forecasting.
Mia Wadelius, Leslie Y Chen, Jonatan D Lindh, Niclas Eriksson, Mohammed J R Ghori, Suzannah Bumpstead, Lennart Holm, Ralph McGinnis, Anders Rane, Panos Deloukas. Blood 2009
409
12

Pharmacogenetic dosing of warfarin in the Han-Chinese population: a randomized trial.
Ming-Shien Wen, Kuan-Cheng Chang, Tsong-Hai Lee, Ying-Fu Chen, Kuo-Chun Hung, Yeu-Jhy Chang, Chia-Wei Liou, Jin-Jer Chen, Chien-Hung Chang, Chao-Yung Wang,[...]. Pharmacogenomics 2017
26
46

Oral anticoagulation: a critique of recent advances and controversies.
Munir Pirmohamed, Farhad Kamali, Ann K Daly, Mia Wadelius. Trends Pharmacol Sci 2015
54
22

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study.
Andrea L Jorgensen, Clare Prince, Gail Fitzgerald, Anita Hanson, Jennifer Downing, Julia Reynolds, J Eunice Zhang, Ana Alfirevic, Munir Pirmohamed. BMC Med 2019
23
52

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
164
11

Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial.
MingSong Wang, XiLong Lang, ShiTao Cui, Ke Fei, LiangJian Zou, Jia Cao, LiangXu Wang, ShengHui Zhang, XinTian Wu, YiLing Wang,[...]. Int J Med Sci 2012
41
26

Warfarin pharmacogenetics.
Julie A Johnson, Larisa H Cavallari. Trends Cardiovasc Med 2015
89
12

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
257
10

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
291
10

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese.
Pei-Chieng Cha, Taisei Mushiroda, Atsushi Takahashi, Michiaki Kubo, Shiro Minami, Naoyuki Kamatani, Yusuke Nakamura. Hum Mol Genet 2010
104
10

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
Vittorio Pengo, Carlo-Federico Zambon, Paola Fogar, Andrea Padoan, Giovanni Nante, Michela Pelloso, Stefania Moz, Anna Chiara Frigo, Francesca Groppa, Dania Bozzato,[...]. PLoS One 2015
26
38

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, Scott C Woller, Kent M Samuelson, Justin W Mansfield, Michelle Robinson, Stephanie Barton, Kim Brunisholz, Chrissa P Mower,[...]. Circulation 2012
168
10

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
261
9

SLCO1B1 variants and statin-induced myopathy--a genomewide study.
E Link, S Parish, J Armitage, L Bowman, S Heath, F Matsuda, I Gut, M Lathrop, R Collins. N Engl J Med 2008
9

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.
Gregory M Cooper, Julie A Johnson, Taimour Y Langaee, Hua Feng, Ian B Stanaway, Ute I Schwarz, Marylyn D Ritchie, C Michael Stein, Dan M Roden, Joshua D Smith,[...]. Blood 2008
319
9

Genetic determinants of response to clopidogrel and cardiovascular events.
Tabassome Simon, Céline Verstuyft, Murielle Mary-Krause, Lina Quteineh, Elodie Drouet, Nicolas Méneveau, P Gabriel Steg, Jean Ferrières, Nicolas Danchin, Laurent Becquemont. N Engl J Med 2009
9

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Changcheng Shi, Wei Yan, Gang Wang, Fei Wang, Qingyu Li, Nengming Lin. PLoS One 2015
35
25

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, Amanda S Grove, Stephanie Barton, Zachery P Nicholas, Samera F S Kahn, Heidi T May, Kent M Samuelson, Joseph B Muhlestein,[...]. Circulation 2007
532
9

Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.
Zhe Xu, Shu-Yu Zhang, Min Huang, Rong Hu, Jia-Li Li, Han-Jin Cen, Zhi-Ping Wang, Jing-Song Ou, Sheng-Li Yin, Ying-Qi Xu,[...]. Ann Thorac Surg 2018
12
75

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
646
9

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
Daniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, Renicus S Hermanides, Arnoud W J van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M Tjon Joe Gin, Folkert W Asselbergs,[...]. N Engl J Med 2019
251
9

Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.
Innocent G Asiimwe, Eunice J Zhang, Rostam Osanlou, Amanda Krause, Chrisly Dillon, Guilherme Suarez-Kurtz, Honghong Zhang, Jamila A Perini, Jessicca Y Renta, Jorge Duconge,[...]. Clin Pharmacol Ther 2020
28
32

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr Drug Metab 2014
243
8

Genetic and clinical predictors of warfarin dose requirements in African Americans.
L H Cavallari, T Y Langaee, K M Momary, N L Shapiro, E A Nutescu, W A Coty, M A G Viana, S R Patel, J A Johnson. Clin Pharmacol Ther 2010
148
8


Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial.
Daniel E Jonas, James P Evans, Howard L McLeod, Shannon Brode, Leslie A Lange, Mary L Young, Betsy Bryant Shilliday, Michelle Martensen Bardsley, Nia J Swinton-Jenkins, Karen E Weck. Pharmacogenomics 2013
47
17


Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Gary Tse, Mengqi Gong, Guangping Li, Sunny Hei Wong, William K K Wu, Wing Tak Wong, Leonardo Roever, Alex Pui Wai Lee, Gregory Y H Lip, Martin C S Wong,[...]. Br J Clin Pharmacol 2018
22
36

A randomized controlled trial of genotype-based Coumadin initiation.
James K Burmester, Richard L Berg, Steven H Yale, Carla M Rottscheit, Ingrid E Glurich, John R Schmelzer, Michael D Caldwell. Genet Med 2011
97
8

Cytochrome p-450 polymorphisms and response to clopidogrel.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William Macias, Eugene Braunwald,[...]. N Engl J Med 2009
8

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
Matthew G McDonald, Mark J Rieder, Mariko Nakano, Clara K Hsia, Allan E Rettie. Mol Pharmacol 2009
219
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.